BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 25291132)

  • 1. Diet, microbiota, and colorectal cancer.
    Akin H; Tözün N
    J Clin Gastroenterol; 2014; 48 Suppl 1():S67-9. PubMed ID: 25291132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?
    Azcárate-Peril MA; Sikes M; Bruno-Bárcena JM
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G401-24. PubMed ID: 21700901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of NMR-based metabolomics to the study of gut microbiota in obesity.
    Calvani R; Brasili E; Praticò G; Sciubba F; Roselli M; Finamore A; Marini F; Marzetti E; Miccheli A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S5-7. PubMed ID: 25291128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
    Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
    Oncol Rep; 2016 Jan; 35(1):325-33. PubMed ID: 26549775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical consequences of diet-induced dysbiosis.
    Chan YK; Estaki M; Gibson DL
    Ann Nutr Metab; 2013; 63 Suppl 2():28-40. PubMed ID: 24217034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.
    Cho M; Carter J; Harari S; Pei Z
    Clin Lab Med; 2014 Dec; 34(4):699-710. PubMed ID: 25439270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
    Serban DE
    Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrients, foods, and colorectal cancer prevention.
    Song M; Garrett WS; Chan AT
    Gastroenterology; 2015 May; 148(6):1244-60.e16. PubMed ID: 25575572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota, diet and health.
    Power SE; O'Toole PW; Stanton C; Ross RP; Fitzgerald GF
    Br J Nutr; 2014 Feb; 111(3):387-402. PubMed ID: 23931069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of pigs as a potential model for research into dietary modulation of the human gut microbiota.
    Heinritz SN; Mosenthin R; Weiss E
    Nutr Res Rev; 2013 Dec; 26(2):191-209. PubMed ID: 24134811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the mechanisms of probiotic actions in the prevention of colorectal cancer.
    Dos Reis SA; da Conceição LL; Siqueira NP; Rosa DD; da Silva LL; Peluzio MD
    Nutr Res; 2017 Jan; 37():1-19. PubMed ID: 28215310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.